Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T16:28:19.953Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:28:19.953Z.

Quote observation: 2026-10-06T16:24:27.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 63,777,806
Total debt · period ending 2026-06-30: 28,743,000
Cash · period ending 2026-06-30: 24,883,000
TTM operating income · period ending 2026-06-30: -97,480,000

FMP input reference: e1640542559587d997c0d8eaeaaf8c892bebef217736e9d4e66575bab6404537

EV/EBITDA|EV/Sales|Operating Income|All Metrics

PLRX EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

EV/EBIT RATIO AVG TTM

N/A

EV/EBIT RATIO AVG 3Y

N/A

EV/EBIT RATIO AVG 5Y

N/A

EV/EBIT RATIO AVG 10Y

N/A

EV/EBIT RATIO AVG 15Y

N/A

EV/EBIT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PLRX Competitors' EV/EBIT Ratio

PLRX

Pliant Therapeutics, Inc.

Current

Market Cap

$63.78M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALPS

Alps Group Inc

vs PLRX

Market Cap

$64.06M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs PLRX

Market Cap

$63.14M

EV/EBIT Ratio

N/A

TTM Avg

9.73x

3Y Avg

23.03x

5Y Avg

21.55x

GOSS

Gossamer Bio, Inc.

vs PLRX

Market Cap

$64.83M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRTX

Heron Therapeutics, Inc.

vs PLRX

Market Cap

$64.85M

EV/EBIT Ratio

N/A

TTM Avg

237.48x

3Y Avg

237.48x

5Y Avg

237.48x

CING

Cingulate Inc.

vs PLRX

Market Cap

$65.86M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNXT

RenovoRx, Inc.

vs PLRX

Market Cap

$66.23M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KLRS

Kalaris Therapeutics Inc

vs PLRX

Market Cap

$61.16M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTB

Connect Biopharma Holdings Limited

vs PLRX

Market Cap

$61.04M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs PLRX

Market Cap

$60.86M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Pliant Therapeutics, Inc. (PLRX)	$63.78M	N/A	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$64.06M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.14M	N/A	9.73x	23.03x	21.55x
Gossamer Bio, Inc. (GOSS)vs ›	$64.83M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$64.85M	N/A	237.48x	237.48x	237.48x
Cingulate Inc. (CING)vs ›	$65.86M	N/A	N/A	N/A	N/A
RenovoRx, Inc. (RNXT)vs ›	$66.23M	N/A	N/A	N/A	N/A
Kalaris Therapeutics Inc (KLRS)vs ›	$61.16M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$61.04M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$60.86M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PLRX EV/EBIT Ratio History

DATE	EV/EBIT RATIO
2021-03-16	66.85x
2021-03-15	66.36x
2021-03-12	66.06x
2021-03-11	66.40x
2021-03-10	66.22x
2021-03-09	66.16x
2021-03-08	59.34x
2021-03-05	54.21x
2021-03-04	55.35x
2021-03-03	62.33x
2021-03-02	63.74x
2021-03-01	61.37x
2021-02-26	57.06x
2021-02-25	69.09x
2021-02-24	69.67x
2021-02-23	58.95x
2021-02-22	60.45x
2021-02-19	57.19x
2021-02-18	52.14x
2021-02-17	55.04x
2021-02-16	56.72x
2021-02-12	53.86x
2021-02-11	51.24x
2021-02-10	49.54x
2021-02-09	55.29x
2021-02-08	53.92x
2021-02-05	58.89x
2021-02-04	53.84x
2021-02-03	52.87x
2021-02-02	52.72x
2021-02-01	42.99x
2021-01-29	41.72x
2021-01-28	42.57x
2021-01-27	44.51x
2021-01-26	46.16x
2021-01-25	46.50x
2021-01-22	45.14x
2021-01-21	44.38x
2021-01-20	43.24x
2021-01-19	44.74x
2021-01-15	44.47x
2021-01-14	44.02x
2021-01-13	47.31x
2021-01-12	47.33x
2021-01-11	46.88x
2021-01-08	46.82x
2021-01-07	47.19x
2021-01-06	46.72x
2021-01-05	42.32x
2021-01-04	41.56x
2020-12-31	38.30x
2020-12-30	39.41x
2020-12-29	41.87x
2020-12-28	42.72x
2020-12-24	43.17x
2020-12-23	43.59x
2020-12-22	44.65x
2020-12-21	43.22x
2020-12-18	43.31x
2020-12-17	46.01x
2020-12-16	47.11x
2020-12-15	49.28x
2020-12-14	46.81x
2020-12-11	45.40x
2020-12-10	46.57x
2020-12-09	44.67x
2020-12-08	47.24x
2020-12-07	46.37x
2020-12-04	48.22x
2020-12-03	48.33x
2020-12-02	48.76x
2020-12-01	51.47x
2020-11-30	46.99x
2020-11-27	56.88x
2020-11-25	51.06x
2020-11-24	50.44x
2020-11-23	49.39x
2020-11-20	48.98x
2020-11-19	46.72x
2020-11-18	44.74x
2020-11-17	49.61x
2020-11-16	44.71x
2020-11-13	41.99x
2020-11-12	43.71x
2020-11-11	42.86x
2020-11-10	4.84x
2020-11-09	4.28x
2020-11-06	3.91x
2020-11-05	4.30x
2020-11-04	3.93x
2020-11-03	3.67x
2020-11-02	3.55x
2020-10-30	3.79x
2020-10-29	3.75x
2020-10-28	3.36x
2020-10-27	4.08x
2020-10-26	4.38x
2020-10-23	4.95x
2020-10-22	4.57x
2020-10-21	4.46x
2020-10-20	4.43x
2020-10-19	5.21x
2020-10-16	5.52x
2020-10-15	5.20x
2020-10-14	4.83x
2020-10-13	5.35x
2020-10-12	5.53x
2020-10-09	5.24x
2020-10-08	4.84x
2020-10-07	5.26x
2020-10-06	3.96x
2020-10-05	3.69x
2020-10-02	2.98x
2020-10-01	2.87x
2020-09-30	4.35x
2020-09-29	4.93x
2020-09-28	4.29x
2020-09-25	3.75x
2020-09-24	4.22x
2020-09-23	4.04x
2020-09-22	4.81x
2020-09-21	5.01x
2020-09-18	7.32x
2020-09-17	7.01x
2020-09-16	6.92x
2020-09-15	6.13x
2020-09-14	6.93x
2020-09-11	6.26x
2020-09-10	6.26x
2020-09-09	5.55x
2020-09-08	5.18x
2020-09-04	4.69x
2020-09-03	5.23x
2020-09-02	5.34x
2020-09-01	5.61x
2020-08-31	5.68x
2020-08-28	6.13x
2020-08-27	5.28x
2020-08-26	5.37x
2020-08-25	5.32x
2020-08-24	5.31x
2020-08-21	5.70x
2020-08-20	5.81x
2020-08-19	5.39x
2020-08-18	5.41x
2020-08-17	5.48x
2020-08-14	5.27x
2020-08-13	5.34x
2020-08-12	5.22x
2020-08-11	34.29x
2020-08-10	34.44x
2020-08-07	33.42x
2020-08-06	32.29x
2020-08-05	30.68x
2020-08-04	30.40x
2020-08-03	30.33x
2020-07-31	29.64x
2020-07-30	30.74x
2020-07-29	31.13x
2020-07-28	31.24x
2020-07-27	31.42x
2020-07-24	30.74x
2020-07-23	33.28x
2020-07-22	32.86x
2020-07-21	35.53x
2020-07-20	35.41x
2020-07-17	31.63x
2020-07-16	31.38x
2020-07-15	28.24x
2020-07-14	28.62x
2020-07-13	28.77x
2020-07-10	32.41x
2020-07-09	33.28x
2020-07-08	34.50x
2020-07-07	35.10x
2020-07-06	37.76x
2020-07-02	38.83x
2020-07-01	38.49x
2020-06-30	43.15x
2020-06-29	47.27x
2020-06-26	42.06x
2020-06-25	41.12x
2020-06-24	40.14x
2020-06-23	38.82x
2020-06-22	36.58x
2020-06-19	36.59x
2020-06-18	34.57x
2020-06-17	33.62x
2020-06-16	32.22x
2020-06-15	33.17x
2020-06-12	28.99x
2020-06-11	28.81x
2020-06-10	29.62x
2020-06-09	27.74x
2020-06-08	29.50x
2020-06-05	28.10x
2020-06-04	29.74x
2020-06-03	26.70x

EV/EBIT Ratio: N/A

PLRX EV/EBIT Ratio Chart

PLRX EV/EBIT Ratio Metrics

PLRX Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

PLRX EV/EBIT Ratio History

Related Metrics